初次CT引导活检分类为机化性肺炎的肺部病变中恶性肿瘤的发生率
回顾性分析1314例因疑似肺癌或转移性疾病行CT引导肺活检的患者,其中98例(7.5%)活检显示机化性肺炎;这98例中11例(11.2%)后续发现恶性肿瘤,包括6例(54.5%)肺转移和5例(45.5%)原发性肺癌。作者认为,当临床高度怀疑恶性肿瘤而初始病理诊断为机化性肺炎时,应考虑重复组织取样。
要点
- 初始活检为机化性肺炎的肺部病变中,11.2%(11/98)后续证实合并恶性肿瘤。
- 后续恶性肿瘤中肺转移占54.5%(6/11),原发性肺癌占45.5%(5/11)。
- 作者建议:临床高度怀疑恶性时,即使病理为机化性肺炎也应考虑重复取样。
核心结论
- 恶性肿瘤可与机化性肺炎共存于初始肺活检中,当临床高度怀疑恶性而初始病理为机化性肺炎时,应考虑重复组织取样。
研究设计与样本
- 回顾性、经IRB批准、符合HIPAA的研究,纳入2014年2月至2022年4月单家三级转诊医院连续1314例因疑似肺癌或转移性疾病行CT引导肺活检的患者,其中98例(7.5%)活检显示机化性肺炎并作为研究队列,通过病历回顾评估临床结局包括随访影像和重复组织取样,采用描述性统计。
诊断标准与关键数值
- 98例初始活检诊断为机化性肺炎的患者中,11例(11.2%)后续发现恶性肿瘤。
- 11例恶性肿瘤中,6例(54.5%)为肺转移,5例(45.5%)为原发性肺癌。
- 恶性肿瘤经皮再活检确诊3/11(27%),经支气管镜、内镜或外科手术确诊8/11(73%)。
临床应用与阅片要点
- 作者建议:当临床高度怀疑恶性肿瘤而初始组织病理诊断为机化性肺炎时,应考虑重复组织取样。
- 作者指出,这在PET/CT显示FDG高摄取、间隔影像显示病灶增大、活检核心尺寸小或活检发生术中并发症的情况下尤其相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Organizing pneumonia is an inflammatory disorder that may co-exist with malignancy in the lung or elsewhere in the body. We aimed to assess patients with a lung biopsy diagnosis of organizing pneumonia for subsequent pathology confirmation of co-existing malignancy.
METHODS: In this retrospective IRB-approved, HIPAA-compliant study, 1314 consecutive patients who underwent CT-guided lung biopsy for suspected lung cancer or metastatic disease from 02/2014 to 04/2022 at a single tertiary referral hospital were identified. In 98/1314 (7.5%) patients, biopsies showed organizing pneumonia, which represented our study cohort. Clinical outcomes, including follow-up imaging and repeat tissue sampling if performed, were evaluated through chart review. Descriptive statistics were calculated.
RESULTS: There were 43/98 (44%) females, mean age was 66 ± 14 years, mean lesion size 2.9 ± 2.1 cm, and 11/98 (11.2%) had prior history of malignancy. Of 98 patients initially diagnosed with organizing pneumonia on lung biopsy, 11 (11.2%) were subsequently found to have malignancy. Among these, 6 (54.5%) had pulmonary metastases and 5 (45.5%) had primary lung cancer. Malignancies were confirmed through percutaneous re-biopsy in 3/11 (27%) and bronchoscopic, endoscopic, or surgical procedures in 8/11 (73%).
CONCLUSION: Malignancy can co-exist with organizing pneumonia in a substantial percentage of initial lung biopsies. Therefore, repeat tissue sampling should be considered when there is high clinical suspicion of malignancy despite an initial histopathological diagnosis of organizing pneumonia. This is especially relevant in lesions that demonstrate FDG avidity on PET/CT or an increase in size on interval imaging, or in instances where the biopsy core sizes are small or where the biopsies have intraprocedural complications.
引用
- Kim C, Liberman Y, Borisovsky G, et al. Incidence of malignancy in lung lesions initially classified as organizing pneumonia on CT-guided biopsies. Abdom Radiol (NY). 2025. PMID: 40504392. doi:10.1007/s00261-025-05048-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。